4.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

(単位:百万円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

流動資産

 

 

現金及び預金

87,064

88,364

受取手形、売掛金及び契約資産

59,238

74,776

電子記録債権

3,561

3,731

商品及び製品

28,419

32,293

仕掛品

6,722

8,153

原材料及び貯蔵品

22,185

23,880

その他

4,992

5,881

貸倒引当金

206

254

流動資産合計

211,978

236,825

固定資産

 

 

有形固定資産

 

 

建物及び構築物

85,849

105,496

減価償却累計額

57,365

71,110

建物及び構築物(純額)

28,483

34,386

機械装置及び運搬具

116,620

127,822

減価償却累計額

99,468

104,164

機械装置及び運搬具(純額)

17,151

23,658

土地

20,343

20,645

リース資産

573

504

減価償却累計額

495

122

リース資産(純額)

77

382

建設仮勘定

15,854

13,776

その他

18,856

20,400

減価償却累計額

15,698

16,522

その他(純額)

3,157

3,878

有形固定資産合計

85,069

96,726

無形固定資産

 

 

その他

1,950

1,918

無形固定資産合計

1,950

1,918

投資その他の資産

 

 

投資有価証券

41,864

46,086

長期貸付金

8

6

繰延税金資産

1,212

1,159

退職給付に係る資産

9,557

13,054

その他

5,707

3,459

貸倒引当金

151

70

投資その他の資産合計

58,198

63,697

固定資産合計

145,218

162,343

資産合計

357,196

399,168

 

 

 

 

(単位:百万円)

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

流動負債

 

 

支払手形及び買掛金

22,305

21,429

電子記録債務

1,580

493

短期借入金

1,490

1,341

1年内返済予定の長期借入金

816

1,013

リース債務

254

269

未払費用

1,904

2,017

未払法人税等

7,682

14,690

預り金

4,328

4,585

賞与引当金

3,915

4,163

資産除去債務

174

109

その他

13,871

36,127

流動負債合計

58,325

86,241

固定負債

 

 

長期借入金

2,008

1,961

リース債務

473

555

繰延税金負債

11,561

9,581

執行役員退職慰労引当金

8

6

退職給付に係る負債

4,976

3,404

資産除去債務

22

23

その他

269

929

固定負債合計

19,321

16,461

負債合計

77,646

102,703

純資産の部

 

 

株主資本

 

 

資本金

17,742

17,742

資本剰余金

15,058

15,058

利益剰余金

220,195

249,159

自己株式

6,271

26,276

株主資本合計

246,724

255,683

その他の包括利益累計額

 

 

その他有価証券評価差額金

21,072

25,271

為替換算調整勘定

6,437

7,973

退職給付に係る調整累計額

4,294

6,417

その他の包括利益累計額合計

31,803

39,662

非支配株主持分

1,022

1,119

純資産合計

279,550

296,465

負債純資産合計

357,196

399,168

 

E0088044030日油株式会社NOF CORPORATION通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2025-04-012026-03-31FY2026-03-312024-04-012025-03-312025-03-311falsefalsefalse440302025-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302025-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302025-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302024-04-012025-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302024-04-012025-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302024-04-012025-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302026-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302026-03-31jpcrp_cor:ReconcilingItemsMember440302025-04-012026-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302025-04-012026-03-31jpcrp_cor:ReconcilingItemsMember440302025-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302025-03-31jpcrp_cor:ReconcilingItemsMember440302024-04-012025-03-31jpcrp_cor:TotalOfReportableSegmentsAndOthersMember440302024-04-012025-03-31jpcrp_cor:ReconcilingItemsMember440302026-03-31jpcrp_cor:ReportableSegmentsMember440302026-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302025-04-012026-03-31jpcrp_cor:ReportableSegmentsMember440302025-04-012026-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302025-03-31jpcrp_cor:ReportableSegmentsMember440302025-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302024-04-012025-03-31jpcrp_cor:ReportableSegmentsMember440302024-04-012025-03-31jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember440302026-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302026-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302026-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302025-04-012026-03-31tse-acedjpfr-44030:FunctionalChemicalsReportableSegmentMember440302025-04-012026-03-31tse-acedjpfr-44030:PharmaceuticalsMedicalsAndHealthReportableSegmentsMember440302025-04-012026-03-31tse-acedjpfr-44030:ExplosiveAndPropulsionReportableSegmentMember440302024-04-012025-03-31jppfs_cor:TreasuryStockMember440302024-04-012025-03-31jppfs_cor:ShareholdersEquityMember440302024-04-012025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302024-04-012025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302024-04-012025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302024-04-012025-03-31jppfs_cor:NonControllingInterestsMember440302024-04-012025-03-31jppfs_cor:CapitalStockMember440302025-03-31jppfs_cor:CapitalStockMember440302025-03-31jppfs_cor:CapitalSurplusMember440302025-03-31jppfs_cor:RetainedEarningsMember440302025-03-31jppfs_cor:TreasuryStockMember440302025-03-31jppfs_cor:ShareholdersEquityMember440302025-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302025-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302025-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302025-03-31jppfs_cor:NonControllingInterestsMember440302026-03-31440302025-04-012026-03-31440302025-03-31440302024-03-31440302024-04-012025-03-31440302026-05-11440302024-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302024-04-012025-03-31jppfs_cor:RetainedEarningsMember440302025-04-012026-03-31jppfs_cor:NonControllingInterestsMember440302026-03-31jppfs_cor:ShareholdersEquityMember440302026-03-31jppfs_cor:CapitalStockMember440302026-03-31jppfs_cor:CapitalSurplusMember440302026-03-31jppfs_cor:RetainedEarningsMember440302026-03-31jppfs_cor:TreasuryStockMember440302026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302026-03-31jppfs_cor:NonControllingInterestsMember440302025-04-012026-03-31jppfs_cor:ShareholdersEquityMember440302025-04-012026-03-31jppfs_cor:CapitalStockMember440302025-04-012026-03-31jppfs_cor:CapitalSurplusMember440302025-04-012026-03-31jppfs_cor:RetainedEarningsMember440302025-04-012026-03-31jppfs_cor:TreasuryStockMember440302025-04-012026-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302025-04-012026-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302025-04-012026-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302024-03-31jppfs_cor:CapitalStockMember440302024-03-31jppfs_cor:CapitalSurplusMember440302024-03-31jppfs_cor:RetainedEarningsMember440302024-03-31jppfs_cor:TreasuryStockMember440302024-03-31jppfs_cor:ShareholdersEquityMember440302024-03-31jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember440302024-03-31jppfs_cor:ForeignCurrencyTranslationAdjustmentMember440302024-03-31jppfs_cor:ValuationAndTranslationAdjustmentsMember440302024-03-31jppfs_cor:NonControllingInterestsMember440302024-04-012025-03-31jppfs_cor:CapitalSurplusMember440302026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302025-04-012026-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember440302024-04-012025-03-31jppfs_cor:RemeasurementsOfDefinedBenefitPlansMemberxbrli:pureiso4217:JPY